Education
About Us
Working with TipRanks
Follow Us
Nath Bio-Genes (India) Ltd. (IN:NATHBIOGEN)
:NATHBIOGEN
Total Valuation
Nath Bio-Genes (India) Ltd. has a market cap or net worth of ₹3.77B. The enterprise value is ₹3.36B.
Market Cap₹3.77B
Enterprise Value₹3.36B
Share Statistics
Nath Bio-Genes (India) Ltd. has 19,004,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding19,004,000
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Nath Bio-Genes (India) Ltd.’s return on equity (ROE) is 0.06 and return on invested capital (ROIC) is 5.67%.
Return on Equity (ROE)0.06
Return on Assets (ROA)0.04
Return on Invested Capital (ROIC)5.67%
Return on Capital Employed (ROCE)0.07
Revenue Per Employee―
Profits Per Employee―
Employee Count―
Asset Turnover0.36
Inventory Turnover0.40
Valuation Ratios
The current PE Ratio of Nath Bio-Genes (India) Ltd. is 7.76. Nath Bio-Genes (India) Ltd.’s PEG ratio is 1.75.
PE Ratio7.76
PS Ratio0.00
PB Ratio1.77
Price to Fair Value0.47
Price to FCF-20.33
Price to Operating Cash Flow-40.94
PEG Ratio1.75
Income Statement
In the last 12 months, Nath Bio-Genes (India) Ltd. had revenue of 3.65B and earned 386.00M in profits. Earnings per share was 19.86.
Revenue3.65B
Gross Profit2.29B
Operating Income459.82M
Pretax Income400.44M
Net Income386.00M
EBITDA497.98M
Earnings Per Share (EPS)19.86
Cash Flow
In the last 12 months, operating cash flow was 0.00 and capital expenditures 0.00, giving a free cash flow of 0.00 billion.
Operating Cash Flow0.00
Free Cash Flow0.00
Free Cash Flow per Share0.00
Dividends & Yields
Nath Bio-Genes (India) Ltd. pays an annual dividend of ₹2, resulting in a dividend yield of 1.01%
Dividend Per Share₹2
Dividend Yield1.01%
Payout Ratio9.28%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.26
52-Week Price Change-3.43%
50-Day Moving Average178.89
200-Day Moving Average183.04
Relative Strength Index (RSI)57.75
Average Volume (3m)4.14K
Important Dates
Nath Bio-Genes (India) Ltd. upcoming earnings date is Aug 7, 2025, TBA Not Confirmed.
Last Earnings DateApr 29, 2025
Next Earnings DateAug 7, 2025
Ex-Dividend DateAug 09, 2024
Financial Position
Nath Bio-Genes (India) Ltd. as a current ratio of 1.89, with Debt / Equity ratio of 11.46%
Current Ratio1.89
Quick Ratio0.96
Debt to Market Cap0.41
Net Debt to EBITDA0.67
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Nath Bio-Genes (India) Ltd. has paid 19.85M in taxes.
Income Tax19.85M
Effective Tax Rate0.05
Enterprise Valuation
Nath Bio-Genes (India) Ltd. EV to EBITDA ratio is 6.69, with an EV/FCF ratio of 34.50.
EV to Sales0.91
EV to EBITDA6.69
EV to Free Cash Flow34.50
EV to Operating Cash Flow18.96
Balance Sheet
Nath Bio-Genes (India) Ltd. has ₹888.99M in cash and marketable securities with ₹1.23B in debt, giving a net cash position of ₹336.01M billion.
Cash & Marketable Securities₹888.99M
Total Debt₹1.23B
Net Cash₹336.01M
Net Cash Per Share₹17.68
Tangible Book Value Per Share₹327.81
Margins
Gross margin is 53.19%, with operating margin of 12.60%, and net profit margin of 10.58%.
Gross Margin53.19%
Operating Margin12.60%
Pretax Margin10.97%
Net Profit Margin10.58%
EBITDA Margin13.65%
EBIT Margin12.60%
Analyst Forecast
The average price target for Nath Bio-Genes (India) Ltd. is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―